Screener
Palvella Therapeutics PVLA Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Palvella Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Palvella Therapeutics’s 10-Q, filed May 15, 2024. Open the filing →
- Filed
- May 15, 2024
- Fiscal quarter
- Q1 FY2024
- Calendar quarter
- Q1 2024
- Accession
- 0001437749-24-017037
FAQ
- What is Palvella Therapeutics's asset turnover?
- Palvella Therapeutics (PVLA) reported asset turnover of 0.7× in Q1 2024.
- How has Palvella Therapeutics's asset turnover changed year-over-year?
- Palvella Therapeutics's asset turnover increased by 376.8% year-over-year, from 0.2× to 0.7×.
- What is the long-term trend for Palvella Therapeutics's asset turnover?
- Over 3 years (2020 to 2023), Palvella Therapeutics's asset turnover has grown at a 51.6% compound annual growth rate (CAGR), from 0.2× to 0.8×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Palvella Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude